Two or more foetal haemoglobin inducers at any dose or duration vs a usual management protocol, placebo or a single foetal haemoglobin inducer
Adverse events · people with non‐transfusion‐dependent β‐thalassaemia
1 finding from 1 review
- Foetal haemoglobin inducers for reducing blood transfusion in non‐transfusion‐dependent beta‐thalassaemias 2023 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 104 participantsVery low